0.18 ML buprenorphine 356 MG/ML Prefilled Syringe [Brixadi]
RxNorm concept 2639039, branded drug (sbd). Prescribable name: Brixadi 64 MG in 0.18 ML Monthly Extended Release Prefilled Syringe.
- RxCUI
- 2639039
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2639039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.18 ML Brixadi 356 MG/ML Prefilled Syringe; Brixadi 64 MG per 0.18 ML extended release Prefilled Syringe
Related concepts
- buprenorphine 356 MG/ML (SCDC, consists of)
- buprenorphine 356 MG/ML [Brixadi] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Brixadi (BN, has ingredient)
- 0.18 ML buprenorphine 356 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2639039 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2639039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2639039. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.